SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 13.66% to Rs. 17962.40 millions for the quarter ended September 2025 as compared to Rs. 15803.50 millions during the corresponding quarter last year.Profit saw a slight increase of 8.19%to Rs. 1793.60  millions from Rs. 1657.80 millions.Operating profit surged to 3148.00 millions from the corresponding previous quarter of 2755.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 17962.40 15803.50 13.66 32904.10 30559.10 7.67 60326.30 58740.60 2.70
Other Income 114.90 160.60 -28.46 192.80 192.00 0.42 478.90 313.20 52.91
PBIDT 3148.00 2755.50 14.24 5363.30 5701.20 -5.93 9492.70 10298.40 -7.82
Interest 228.10 182.80 24.78 454.50 309.70 46.75 764.70 544.70 40.39
PBDT 2919.90 2701.40 8.09 4908.80 5520.20 -11.08 8856.70 9753.70 -9.20
Depreciation 756.40 701.20 7.87 1490.10 1388.00 7.36 2770.80 2711.40 2.19
PBT 2163.50 2000.20 8.16 3418.70 4132.20 -17.27 6085.90 7042.30 -13.58
TAX 369.90 342.40 8.03 589.90 712.50 -17.21 1054.70 377.50 179.39
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1793.60 1657.80 8.19 2828.80 3419.70 -17.28 5031.20 6664.80 -24.51
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 17.53 17.44 0.51 16.30 18.66 -12.63 15.74 17.53 -10.25

Alembic Pharma Share Price

772.85 -12.10 (-1.54%)
20-Apr-2026 12:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.80
Dr. Reddys Lab 1238.00
Cipla 1238.25
Zydus Lifesciences 942.95
Lupin 2333.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×